Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy

Chronic kidney disease (CKD) is a worldwide public health threat that increases risk of death due to cardiovascular complications, including left ventricular hypertrophy (LVH). Novel therapeutic targets are needed to design treatments to alleviate the cardiovascular burden of CKD. Previously, we dem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Metab
Main Authors: Grabner, Alexander, Amaral, Ansel P., Schramm, Karla, Singh, Saurav, Sloan, Alexis, Yanucil, Christopher, Li, Jihe, Shehadeh, Lina A., Hare, Joshua M., David, Valentin, Martin, Aline, Fornoni, Alessia, Marco, Giovana Seno Di, Kentrup, Dominik, Reuter, Stefan, Mayer, Anna B., Pavenstädt, Hermann, Stypmann, Jörg, Kuhn, Christian, Hille, Susanne, Frey, Norbert, Leifheit-Nestler, Maren, Richter, Beatrice, Haffner, Dieter, Abraham, Reimar, Bange, Johannes, Sperl, Bianca, Ullrich, Axel, Brand, Marcus, Wolf, Myles, Faul, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4670583/
https://ncbi.nlm.nih.gov/pubmed/26437603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2015.09.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados